Posts

Private equity deals in pharmaceutical in China increas...

In China pharmaceutical industry, there were 6 private equity deals announced in...

STAT+: Mental illness, drug addiction go hand in glove,...

WASHINGTON — At a House oversight hearing Thursday, the Biden administration’s t...

STAT+: Lawmakers circle parents’ rights in gender-affir...

Republicans on Thursday sought to turn around transgender advocates’ arguments t...

STAT+: Mitch McConnell’s abrupt episode has an importan...

"Time is brain. So if you are having a stroke, it's important to get access to c...

To spread or slide? Scientists uncover how foams are sp...

Tokyo, Japan – Researchers from Tokyo Metropolitan University have uncovered the...

GSK’s HIV prevention drug moves toward marketing approv...

GSK Plc announced on Monday that ViiV Healthcare, its subsidiary focused on HIV ...

J&J, GSK Indicate Cabenuva Preference Over Gilead Rival

In order to make Cabenuva the conventional treatment choice for HIV, Johnson & J...

Glucotrack’s CGM Implant Clears First Feasibility Study

Continuous glucose monitors (CGMs) have become a breakthrough in diabetes manage...

Eli Lilly’s Obesity Drug Performs Well in Two Late-Stag...

Eli Lilly announced that its experimental obesity medicine helped patients lose ...

How did hiring in the Chinese pharma industry perform i...

The Chinese pharma industry experienced a 51% rise in hiring activity in Q2 2023...

How did hiring in the Asia-Pacific pharma industry perf...

The Asia-Pacific pharma industry experienced a 4% drop in hiring activity in Q2 ...

Inflationary pressure causes drop-off in contract manuf...

As several economies deal with inflation, there has been a reduction in deals in...

Bernie Sanders plans more drug price caps as big pharma...

Senator Bernie Sanders has proposed price caps on drugs developed with federal f...

Carmell to merge with regenerative medicine company Axo...

Carmell Therapeutics has entered a definitive agreement and plan of merger with ...

Bristol Myers Squibb reports 6% drop in Q2 2023 revenues

Bristol Myers Squibb has reported revenues of $11.2bn in the second quarter of 2...

InSilicoTrials and Axoltis to develop drugs for neurolo...

InSilicoTrials has entered a partnership with Axoltis Pharma for the advancement...